key: cord-1033885-5yb5w2gr
authors: Al-Smadi, Anas S.; Mach, John C.; Abrol, Srishti; Luqman, Ali; Chamiraju, Parthasarathi; Abujudeh, Hani
title: Endovascular Thrombectomy of COVID-19-Related Large Vessel Occlusion: A Systematic Review and Summary of the Literature
date: 2021-03-08
journal: Curr Radiol Rep
DOI: 10.1007/s40134-021-00379-1
sha: 6d8f748e884a1736eb75f2c1387749aab9d799f8
doc_id: 1033885
cord_uid: 5yb5w2gr

PURPOSE: Despite an overall reduction in the number of stroke cases presenting to hospitals during the COVID-19 pandemic, a remarkably high incidence of acute cerebrovascular disease associated with the infection has been reported. In this systematic review, we assess the neurological outcomes and complications of endovascular thrombectomy (EVT) for large vessel occlusions (LVO) in COVID-19 patients. METHODS: A literature search was performed in PubMed from December 1, 2019 through September 1st, 2020 using different combinations of suitable keywords. Ten studies reporting EVT outcomes and complications were identified. Two studies that included non-LVO pathologies and COVID-19 negative patients with the outcomes analysis were excluded. Patient demographics, comorbidities, anatomic thrombus location, neurological and angiographic outcomes were assessed. RESULTS: A total of 8 studies, in addition to our institutional case series, were ultimately included in this review. The mean age was 62.2 years, of which 67.6% were males. M1 segment involvement was the most commonly reported (53.8%) thrombus location. The mean NIHSS at presentation was 20.4 with no significant change at 24 h. Successful revascularization (TICI ≥ 2b) was achieved in 89%. Early proximal cerebral re-occlusion was reported in 6 patients (11%) and cerebral hemorrhage in 3 patients (4%). In hospital mortality was reported in 15 patients (28.8%). CONCLUSION: Despite angiographically successful EVT of LVOs in the majority of patients, this literature analysis demonstrates overall poor outcomes and high mortality in COVID-19 patients post EVT. An unusual incidence of early intracerebral proximal arterial re-occlusion was notable.

Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is a new strain of the coronavirus family that emerged in 2019 and was first reported in Wuhan, China, but spread exponentially to become a worldwide pandemic in months. Infection with SARS-Cov-2 primarily presents as a severe acute respiratory illness in human subjects [1] .

Understanding of the 2019-coronavirus disease (COVID-19) has evolved significantly over time. In addition to respiratory symptoms, COVID-19 may present with various gastrointestinal, renal, neurological and cardiovascular symptoms [2, 3] . Attention has been drawn recently to the thromboembolic sequelae of this disease, including ischemic strokes, due to the severe outcomes associated with these complication [4] [5] [6] . Despite a significant overall reduction in the number of stroke cases presenting to hospitals during the pandemic, studies have This article is part of the Topical collection on Quality and Safety.

& John C. Mach john.charles.mach@gmail.com

Hani Abujudeh HAbujude@dmc.org demonstrated a remarkably high incidence of acute cerebrovascular disease in those with COVID-19 [7] [8] [9] . Although the indications for endovascular thrombectomy (EVT) of COVID-19 related large vessel occlusions (LVOs) are the same as for the general population, a protected code stroke algorithm has been introduced to expedite management while also ensuring the safety of healthcare providers [10] [11] [12] . In this study, we employed meta-analytic techniques to pool data from the literature to explore the outcomes and potential complications of EVT among COVID-19 patients.

Institutional review board approval was obtained for a retrospective study of COVID-19 positive patients with large vessel occlusions (LVO) who underwent endovascular intervention between March 1 and June 20. Informed consent was waived. We studied patients' demographics, clinical presentations, laboratory findings, National Institutes of Health Stroke Scale (NIHSS), CT angiography (CTA) and CT perfusion (CTP) findings, mechanical thrombectomy procedure, immediate post-procedural outcome and neurological outcome at final follow-up whenever available. 

In our series, we identified 3 patients (mean age 64.3 ± 15.1) with findings consistent with acute stroke on non-contrast head CT, followed by CTA head and CT perfusion studies (An example is demonstrated Fig. 1 ). All the 3 patients had a sizeable ischemic penumbra and were deemed candidates for EVT according to Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 (DEFUSE 3) criteria [13] . Two patients had anterior circulation LVO and one patient with posterior circulation LVO. Clinical presentation, treatment and outcome are detailed in (Table 1) . A total of 635 abstracts were identified from the literature search, from which 35 were identified for detailed review. Eight studies, including our case series, consisting of 73 patients were included for final analysis ( Table 2 ). The average age of the included patients was 62.2 years, 67.6% of whom were male. All but one study included demographic data regarding vascular comorbidities. Of these, hypertension was the most prevalent (59.7%, n = 43), followed by diabetes (30.6%, n = 22), atrial fibrillation (18.5%), and hyperlipidemia (15.4%). Six studies described the basic anatomic location of cerebral thrombus location, 65.7% (n = 48) of which involved the anterior circulation. Involvement of the M1 segment was most commonly reported (53.8%). Involvement of multiple vascular territories was noted in 34.6% of cases. Carotid involvement occurred in 19.2% of cases. The mean NIHSS at presentation was 20.4 .

In total, 47.9% (n = 35) of patients received tPA and 89% (n = 65) underwent endovascular thrombectomy. Four studies describing 42 patients provided technical EVT details. The most utilized methods were the ADAPT technique (40.5%, n = 17) and stent-aspiration combination (33.3%, n = 14). Suction aspiration only and stent retrieval were used as primary techniques in 16.7% (n = 7) and 9.5% patients (n = 4), respectively (Table 3) .

TICI C 2b was reported in 83.1% (n = 54) of cases. The mean NIHSS at 24 h after presentation (documented in three studies) was 20 (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) , representing no significant difference compared to NIHSS at presentation. Six patients were reported to have early cerebral re-occlusion and cerebral hemorrhage occurred in three patients during the post-procedural period. In-hospital mortality was reported in 28.8% (n = 15) of patients (Table 3) . 

The COVID-19 pandemic has demonstrated a direct and indirect impact on the occurrence and presentation of acute cerebrovascular disease. The known associated prothrombotic state leading to arterial and venous thrombosis has contributed to stroke being the most commonly reported neurological complication [4, 6] . Using meta-analytic methodology to analyze outcomes data following EVT, our study highlights the various challenges of treating COVID-19 patients presenting with stroke. Although COVID-19 related LVO has been reported in young patients less than 50 years old, the mean age of this patients' pool was 62.2 years and is comparable to the mean of 68 years in pre-pandemic reports [8, 14, 15, 16 • , 17] . This review found the NIHSS at presentation among COVID-19 patients is typically moderate to severe with a mean of 20.4 (range 7-40), consistent with a recent systematic review that reported a mean of 19 [18 • ]. In the series of patients from our institution, the two patients with anterior circulation LVO had NIHSS of 12 and 17 comparable to large-scale EVT trials who report an NIHSS range of 14-20 (mean of 17) [17] . This contrasts to the NIHSS of 40 in the patient with basilar occlusion, which was reported in 12.5% of the overall included patient pool. Re-evaluation of the NIHSS at 24 h after presentation, which was reported in three of the eight studies, demonstrated no significant difference with the NIHSS at presentation, suggesting EVT has minimal effect in the acute phase [19, 20 • ].

A small but significant proportion of the patients who underwent EVT (8%) had early proximal arterial re-occlusion after a successful thrombectomy. Overall post procedure intracerebral hemorrhage was 4%, which is comparable to previous EVT trials [17] . Though successful revascularization (TICI C 2b) was achieved in 83% of patients regardless of technique used, the in-hospital mortality rate was high at 28.8% compared to 15.3% among non-COVID-19 patients [17] . In our series of patients, persistent neurological deficits were noted in two patients and one patient ultimately died from stroke and COVID-19 related respiratory complications. Despite a high proportion of successful angiographic results, these relatively poor outcomes compared to non-COVID-19 stroke patients may be attributed to differences in clot composition, with an increased tendency for clot fragmentation and migration that results in microemboli as described by Wang et al. [16 • ]. The sequalae of such microemboli are further exacerbated by the severity of the underlying COVID-19 respiratory disease that in conjunction with stroke indicates a worse overall prognosis [6] .

Recent literature has reported the incidence of stroke among COVID-19 patients to range between 1.1 and 5.7% [5, 6, 9, 21, 22] . However, as patients with multiple cardiovascular risk factors are significantly more likely to develop severe COVID-19 disease as well as acute cerebrovascular disease, the association between COVID-19 and stroke is complex [23, 24] . Future research that employ multi-institutional cohorts of larger patient populations will be required to more clearly elucidate the relationship between comorbidities and LVOs related to COVID-19.

Our results are subject to inherent limitations of the retrospective nature of case series and case reports, including significant heterogeneity of included studies. Furthermore, several of the studies included in this systematic review failed to report relevant variables such as NIHSS at 24 h and mRS, and most of these were reported on a mean basis making it difficult to evaluate the progression or outcome of each patient. Future studies with a larger cohort and more detailed long-term neurological follow-up are required.

This systematic literature analysis demonstrates overall poor outcomes and high mortality in COVID-19 patients presenting with stroke despite angiographically successful EVT of LVOs in the majority of patients. An unusual incidence of early intracerebral proximal arterial re-occlusion and propensity for clot fragmentation and microemboli may be significant contributing factors. Early cerebral re-occlusion, n (%) 6 (9.2)

Post-procedural hemorrhage, n (%) 3 (5.6)

Conflict of interest No conflicts of interest to declare.

Disclosure No authors have financial relationships relevant to this article to disclose.

The first 75 days of novel coronavirus (SARS-CoV-2) outbreak: recent advances, prevention, and treatment

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Clinical characteristics of coronavirus disease 2019 in China

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome

COVID-19 and stroke-a global world stroke organization perspective

Mechanical thrombectomy for acute ischemic stroke amid the COVID-19 outbreak: decreased activity, and increased care delays

Risk of ischemic stroke in patients with Covid-19 versus patients with influenza

Preserving access: a review of stroke thrombectomy during the COVID-19 pandemic

Society of NeuroInterventional Surgery recommendations for the care of emergent neurointerventional patients in the setting of COVID-19

Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging

COVID-19 related stroke in young individuals

Large-vessel stroke as a presenting feature of Covid-19 in the young

This study detalis institutional experience with mechanical thrombectomies of COVID-19 patients and hypothesis of the propensity of the clots

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials

This study's pool data demonstrates the high mortality rate of COVID-19 patients complicated by ischemic stroke

Large vessel stroke in six patients following SARS-CoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease

Treatment of acute ischemic stroke due to large vessel occlusion with COVID-19: experience from Paris

Acute cerebrovascular disease following COVID-19: a single center

Neurologic manifestations of hospitalized patients with coronavirus disease

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Large artery ischemic stroke in severe COVID-19

Early brain imaging shows increased severity of acute ischemic strokes with large vessel occlusion in COVID-19 patients

Beaujeux R. Stroke thrombectomy in patients with COVID-19: initial experience in 13 cases

Severe acute respiratory syndrome coronavirus 2 infection and ischemic

Impact of COVID-19 on neurological manifestations: an overview of stroke presentation in pandemic

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations